Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines.
Laura Sánchez de PradaIvan Sanz-MuñozJavier Castrodeza SanzRaúl Ortiz de Lejarazu LeonardoJosé María Eiros-BouzaPublished in: Vaccines (2020)
The AIV presents better performance against the A(H3N2) subtype in the elderly whereas the NAIV induces a better response against A(H1N1)pdm09 in the same group.
Keyphrases